Kate D Sutherland (Kate Sutherland)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 19

Top Topics

Epidermal Growth Factor Receptor

Monoclonal Antibody

Small Cell Lung Cancer

Top Venues

Cell death and differentiation

Clinical cancer research : an official journal of the American Association for Cancer Research

Cell cycle (Georgetown, Tex.)

This page only lists publications with an associated author ORCID identifier.

Publications

Jin Ng, Ling Cai, Luc Girard, Owen William John Prall, Neeha Rajan, Christine Khoo, Ahida Batrouney, David J Byrne, Danielle K Boyd, Ariena J Kersbergen, Michael Christie, John D Minna, Marian L Burr, Kate D Sutherland
Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Jin Ng, Ling Cai, Luc Girard, Owen William John Prall, Neeha Rajan, Christine Khoo, Ahida Batrouney, David J Byrne, Danielle K Boyd, Ariena J Kersbergen, Michael Christie, John D Minna, Marian L Burr, Kate D Sutherland
Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Jin Ng, Ling Cai, Luc Girard, Owen William John Prall, Neeha Rajan, Christine Khoo, Ahida Batrouney, David J Byrne, Danielle K Boyd, Ariena J Kersbergen, Michael Christie, John D Minna, Marian L Burr, Kate D Sutherland
Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Jin Ng, Ling Cai, Luc Girard, Owen William John Prall, Neeha Rajan, Christine Khoo, Ahida Batrouney, David J Byrne, Danielle K Boyd, Ariena J Kersbergen, Michael Christie, John D Minna, Marian L Burr, Kate D Sutherland
Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Zilu Wang, Huimin Hu, Luuk Heitink, Kelly L Rogers, Yue You, Tao Tan, Connie Li Wai Suen, Alex Garnham, Hao Chen, Elizabeth Lieschke, Sarah T Diepstraten, Catherine Chang, Tianwei Chen, Diane Moujalled, Kate D Sutherland, Guillaume L Lessene, Oliver M Sieber, Jane Visvader, Gemma L Kelly, Andreas Strasser
The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cells. Cell death and differentiation (2023)
Zilu Wang, Huimin Hu, Luuk Heitink, Kelly L Rogers, Yue You, Tao Tan, Connie Li Wai Suen, Alex Garnham, Hao Chen, Elizabeth Lieschke, Sarah T Diepstraten, Catherine Chang, Tianwei Chen, Diane Moujalled, Kate D Sutherland, Guillaume L Lessene, Oliver M Sieber, Jane Visvader, Gemma L Kelly, Andreas Strasser
Correction to: The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cells. Cell death and differentiation (2023)
Zilu Wang, Huimin Hu, Luuk Heitink, Kelly L Rogers, Yue You, Tao Tan, Connie Li Wai Suen, Alex Garnham, Hao Chen, Elizabeth Lieschke, Sarah T Diepstraten, Catherine Chang, Tianwei Chen, Diane Moujalled, Kate D Sutherland, Guillaume L Lessene, Oliver M Sieber, Jane Visvader, Gemma L Kelly, Andreas Strasser
Correction to: The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cells. Cell death and differentiation (2023)
Zilu Wang, Huimin Hu, Luuk Heitink, Kelly L Rogers, Yue You, Tao Tan, Connie Li Wai Suen, Alex Garnham, Hao Chen, Elizabeth Lieschke, Sarah T Diepstraten, Catherine Chang, Diane Moujalled, Kate D Sutherland, Guillaume L Lessene, Oliver M Sieber, Jane Visvader, Gemma L Kelly, Andreas Strasser
The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cells. Cell death and differentiation (2023)
Zilu Wang, Huimin Hu, Luuk Heitink, Kelly L Rogers, Yue You, Tao Tan, Connie Li Wai Suen, Alex Garnham, Hao Chen, Elizabeth Lieschke, Sarah T Diepstraten, Catherine Chang, Diane Moujalled, Kate D Sutherland, Guillaume L Lessene, Oliver M Sieber, Jane Visvader, Gemma L Kelly, Andreas Strasser
The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cells. Cell death and differentiation (2023)
Zilu Wang, Huimin Hu, Luuk Heitink, Kelly L Rogers, Yue You, Tao Tan, Connie Li Wai Suen, Alex Garnham, Hao Chen, Elizabeth Lieschke, Sarah T Diepstraten, Catherine Chang, Tianwei Chen, Diane Moujalled, Kate D Sutherland, Guillaume L Lessene, Oliver M Sieber, Jane Visvader, Gemma L Kelly, Andreas Strasser
The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cells. Cell death and differentiation (2023)
Joseph B Hiatt, Holly Sandborg, Sarah M Garrison, Henry U Arnold, Sheng-You Liao, Justin P Norton, Travis J Friesen, Feinan Wu, Kate D Sutherland, Hugh Young Rienhoff, Renato Martins, A McGarry Houghton, Shivani Srivastava, David MacPherson
Inhibition of LSD1 with Bomedemstat Sensitizes Small Cell Lung Cancer to Immune Checkpoint Blockade and T-Cell Killing. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (20) (2022)
Kate D Sutherland, Abbie S Ireland, Trudy G Oliver
Killing SCLC: insights into how to target a shapeshifting tumor. Genes & development 36 (5-6) (2022)
Lahiru Gangoda, Robyn L Schenk, Sarah A Best, Christina Nedeva, Cynthia Louis, Damian B D'Silva, Kirsten Fairfax, Andrew G Jarnicki, Hamsa Puthalakath, Kate D Sutherland, Andreas Strasser, Marco J Herold
Absence of pro-survival A1 has no impact on inflammatory cell survival in vivo during acute lung inflammation and peritonitis. Cell death and differentiation (2021)
Sarah A Best, Cassandra J Vandenberg, Etna Abad, Lachlan W Whitehead, Laia Guiu, Sheryl Ding, Margs S Brennan, Andreas Strasser, Marco J Herold, Kate D Sutherland, Ana Janic
Consequences of Zmat3 loss in c-MYC- and mutant KRAS-driven tumorigenesis. Cell death & disease 11 (10) (2020)
Stephanie R Hyslop, Marliese Alexander, Alesha A Thai, Ariena Kersbergen, Andrew J Kueh, Marco J Herold, Jason Corbin, Pradnya Gangatirkar, Ashley P Ng, Benjamin J Solomon, Warren S Alexander, Kate D Sutherland, Emma C Josefsson
Targeting platelets for improved outcome in KRAS-driven lung adenocarcinoma. Oncogene 39 (29) (2020)
Sarah A Best, Sheryl Ding, Ariena Kersbergen, Xueyi Dong, Ji-Ying Song, Yi Xie, Boris Reljic, Kaiming Li, James E Vince, Vivek Rathi, Gavin M Wright, Matthew E Ritchie, Kate D Sutherland
Distinct initiating events underpin the immune and metabolic heterogeneity of KRAS-mutant lung adenocarcinoma. Nature communications 10 (1) (2019)
Lahiru Gangoda, Charis E Teh, Michael A Dengler, Sarah A Best, Clare E Weeden, Lin Tai, Erinna F Lee, Walter D Fairlie, Kate D Sutherland, Leonard C Harrison, Daniel H D Gray, Andreas Strasser, Marco J Herold
Characterization of a novel human BFL-1-specific monoclonal antibody. Cell death and differentiation 27 (2) (2019)
Sarah A Best, Kate D Sutherland
"Keaping" a lid on lung cancer: the Keap1-Nrf2 pathway. Cell cycle (Georgetown, Tex.) 17 (14) (2018)
Sarah A Best, Cassandra R Harapas, Ariena Kersbergen, Vivek Rathi, Marie-Liesse Asselin-Labat, Kate D Sutherland
FGFR3-TACC3 is an oncogenic fusion protein in respiratory epithelium. Oncogene 37 (46) (2018)